Cargando…

Three-dimensional tumor cell cultures employed in virotherapy research

Oncolytic virotherapy constitutes an upcoming alternative treatment option for a broad spectrum of cancer entities. However, despite great research efforts, there is still only a single US Food and Drug Administration/European Medicines Agency-approved oncolytic virus available for clinical use. One...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kloker, Linus D, Yurttas, Can, Lauer, Ulrich M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130269/ https://www.ncbi.nlm.nih.gov/pubmed/30234074 http://dx.doi.org/10.2147/OV.S165479

Ejemplares similares

Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapy
por: Binz, Eike, et al.
Publicado: (2015)

Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model
por: Koch, Jana, et al.
Publicado: (2023)

A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy
por: Carter, Mary E., et al.
Publicado: (2022)

Oncolytic Virotherapy in Glioma Tumors
por: Rius-Rocabert, Sergio, et al.
Publicado: (2020)

Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms
por: Kloker, Linus D., et al.
Publicado: (2020)

Optical Detection and Virotherapy of Live Metastatic Tumor Cells in Body Fluids with Vaccinia Strains
por: Wang, Huiqiang, et al.
Publicado: (2013)

Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy
por: Klose, Chihab, et al.
Publicado: (2019)

Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements
por: Jin, Ke-Tao, et al.
Publicado: (2021)

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
por: Enow, Junior A., et al.
Publicado: (2023)

Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models
por: Bhattacharya, Somshuvra, et al.
Publicado: (2020)

Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus
por: Scheubeck, Gabriel, et al.
Publicado: (2019)

Virotherapy in Cancer
por: Motalleb, Gholamreza
Publicado: (2013)

Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research
por: Doctor, Alina, et al.
Publicado: (2020)

Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?
por: Denton, Nicholas L., et al.
Publicado: (2016)

Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy
por: Wang, Xianwang, et al.
Publicado: (2023)

Oncolytic Virotherapy: The Cancer Cell Side
por: Ehrlich, Marcelo, et al.
Publicado: (2021)

Three-Dimensional Culture Systems in Gastric Cancer Research
por: Alzeeb, George, et al.
Publicado: (2020)

Three-dimensional in vitro culture models in oncology research
por: Jubelin, Camille, et al.
Publicado: (2022)

Mimicking Tumor Hypoxia in Non-Small Cell Lung Cancer Employing Three-Dimensional In Vitro Models
por: Ziółkowska-Suchanek, Iwona
Publicado: (2021)

Attenuated and Protease-Profile Modified Sendai Virus Vectors as a New Tool for Virotherapy of Solid Tumors
por: Zimmermann, Martina, et al.
Publicado: (2014)

Targeting tumor vasculature through oncolytic virotherapy: recent advances
por: Toro Bejarano, Marcela, et al.
Publicado: (2015)

Design Strategies and Precautions for Using Vaccinia Virus in Tumor Virotherapy
por: Liu, Xinjun, et al.
Publicado: (2022)

Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy
por: Wang, Xianyao, et al.
Publicado: (2021)

Cross Talk of Macrophages with Tumor Microenvironment Cells and Modulation of Macrophages in Cancer by Virotherapy
por: Di Somma, Sarah, et al.
Publicado: (2021)

Basic stochastic model for tumor virotherapy
por: Phan, Tuan Anh, et al.
Publicado: (2020)

Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020)

Oncolytic virotherapy for head and neck cancer: current research and future developments
por: Malhotra, Akshiv, et al.
Publicado: (2015)

Three-Dimensional Cell Co-Culture Liver Models and Their Applications in Pharmaceutical Research
por: Ma, Yinping, et al.
Publicado: (2023)

Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies
por: Nettelbeck, Dirk M., et al.
Publicado: (2021)

Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy
por: Bressy, Christian, et al.
Publicado: (2017)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012)

New Frontiers in Three-Dimensional Culture Platforms to Improve Diabetes Research
por: Mohandas, Sundhar, et al.
Publicado: (2023)

Emerging role of Natural killer cells in oncolytic virotherapy
por: Bhat, Rauf, et al.
Publicado: (2015)

Oncolytic Virotherapy of Canine and Feline Cancer
por: Gentschev, Ivaylo, et al.
Publicado: (2014)

Oncolytic virotherapy for advanced liver tumours
por: Chang, Ju-Fang, et al.
Publicado: (2009)

Virotherapy: cancer gene therapy at last?
por: Bilsland, Alan E., et al.
Publicado: (2016)

Oncolytic Virotherapy for Cancer: Clinical Experience
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
por: Marchica, Valentina, et al.
Publicado: (2021)

The Multifaceted Role of Macrophages in Oncolytic Virotherapy
por: Hofman, Laura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u9j39agkui31djsm2ov6kcri43